 |
인쇄하기
취소
|
KFDA okayed Iressa sales in Korea.
The KFDA approved Iressa, a non-small lung cancer drug developed by Astra Zeneca on June 14 after clearing the comparative dissolution test problems.
The registration in Korea will be the 6th after Japan, America, Australia, Singapore and Argentina for the treatment of non-small lung cancer of which other chemotherapy treatments be failed.
The KFDA conditionally granted its registration w...
The registration in Korea will be the 6th after Japan, America, Australia, Singapore and Argentina for the treatment of non-small lung cancer of which other chemotherapy treatments be failed.
The KFDA conditionally granted its registration w...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.